Natural Progression of Left Ventricular Function following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis.

Ainsley Ryan Yan Bin LeeChun En YauChen Ee LowJiaqi LiSara Moiz TyeballyWeiqin LinLi-Ling TanChia-Te LiaoWei-Ting ChangMatilda Xinwei LeeChieh Yang Koo Ching-Hui Sia

Published in: Cancers (2023)

While the mean LVEF decline in patients without cardioprotective therapy was clinically small, a vulnerable subset experienced significant impairment. Further research to best identify those who benefit most from cardioprotective therapies when receiving anthracyclines is required.

Keyphrases

left ventricular
end stage renal disease
newly diagnosed
chronic kidney disease
heart failure
peritoneal dialysis
acute myocardial infarction
stem cells
mitral valve
mesenchymal stem cells
coronary artery disease
cell therapy
aortic stenosis
left atrial
aortic valve